Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1963 3
1964 3
1965 1
1966 2
1967 1
1968 4
1969 6
1970 2
1971 1
1972 1
1973 4
1974 4
1975 4
1976 4
1977 4
1978 7
1979 5
1980 6
1981 6
1982 6
1983 11
1984 9
1985 12
1986 11
1987 6
1988 10
1989 8
1990 10
1991 10
1992 4
1993 5
1994 8
1995 5
1996 8
1997 2
1998 3
1999 2
2000 2
2001 5
2002 2
2003 6
2004 4
2005 7
2006 5
2007 3
2008 3
2009 10
2010 4
2011 1
2012 2
2013 4
2014 3
2015 1
2016 2
2017 4
2018 5
2019 3
2020 4
2021 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

278 results

Results by year

Filters applied: . Clear all
Page 1
Aromatic sulphonamides of aziridine-2-carboxylic acid derivatives as novel PDIA1 and PDIA3 inhibitors.
Zelencova-Gopejenko D, Andrianov V, Domracheva I, Kanepe-Lapsa I, Milczarek M, Stojak M, Przyborowski K, Fedak FA, Walczak M, Kramkowski K, Wietrzyk J, Chlopicki S, Kalvins I. Zelencova-Gopejenko D, et al. Among authors: andrianov v. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2158187. doi: 10.1080/14756366.2022.2158187. J Enzyme Inhib Med Chem. 2023. PMID: 37070480 Free PMC article.
Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma.
Subbiah V, Chawla SP, Conley AP, Wilky BA, Tolcher A, Lakhani NJ, Berz D, Andrianov V, Crago W, Holcomb M, Hussain A, Veldstra C, Kalabus J, O'Neill B, Senne L, Rowell E, Heidt AB, Willis KM, Eckelman BP. Subbiah V, et al. Among authors: andrianov v. Clin Cancer Res. 2023 Aug 15;29(16):2988-3003. doi: 10.1158/1078-0432.CCR-23-0974. Clin Cancer Res. 2023. PMID: 37265425 Free PMC article. Clinical Trial.
Molecular Bases of Brain Preconditioning.
Deryagin OG, Gavrilova SA, Gainutdinov KL, Golubeva AV, Andrianov VV, Yafarova GG, Buravkov SV, Koshelev VB. Deryagin OG, et al. Among authors: andrianov vv. Front Neurosci. 2017 Jul 25;11:427. doi: 10.3389/fnins.2017.00427. eCollection 2017. Front Neurosci. 2017. PMID: 28790886 Free PMC article.
Exploring Aspartic Protease Inhibitor Binding to Design Selective Antimalarials.
Bobrovs R, Basens EE, Drunka L, Kanepe I, Matisone S, Velins KK, Andrianov V, Leitis G, Zelencova-Gopejenko D, Rasina D, Jirgensons A, Jaudzems K. Bobrovs R, et al. Among authors: andrianov v. J Chem Inf Model. 2022 Jul 11;62(13):3263-3273. doi: 10.1021/acs.jcim.2c00422. Epub 2022 Jun 17. J Chem Inf Model. 2022. PMID: 35712895
Investigation of NO Role in Neural Tissue in Brain and Spinal Cord Injury.
Andrianov VV, Kulchitsky VA, Yafarova GG, Bazan LV, Bogodvid TK, Deryabina IB, Muranova LN, Silantyeva DI, Arslanov AI, Paveliev MN, Fedorova EV, Filipovich TA, Nagibov AV, Gainutdinov KL. Andrianov VV, et al. Molecules. 2023 Oct 31;28(21):7359. doi: 10.3390/molecules28217359. Molecules. 2023. PMID: 37959778 Free PMC article.
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer.
Liao C, Zhang Y, Fan C, Herring LE, Liu J, Locasale JW, Takada M, Zhou J, Zurlo G, Hu L, Simon JM, Ptacek TS, Andrianov VG, Loza E, Peng Y, Yang H, Perou CM, Zhang Q. Liao C, et al. Among authors: andrianov vg. Cancer Discov. 2020 Nov;10(11):1706-1721. doi: 10.1158/2159-8290.CD-20-0288. Epub 2020 Jul 20. Cancer Discov. 2020. PMID: 32690540 Free PMC article.
278 results